i3 2022i3 2022 day 1

Introduction & Welcome Keynote

Christian Marcazzo,
General Manager, IDBS

See all i3 2022 Sessions

Christian Marcazzo, General Manager of IDBS, outlines the key areas of customer focus and growth for IDBS, both in product development and geographically; including how the acquisition of Skyland PIMS® helps add value in the BioPharma lifecycle, particularly in manufacturing and tech transfer, helping our customers scale up to bring new therapies to market faster.

Watch the Session

You may also like these sessions:

Accelerating Time-to-Insight

22nd June 2022 | 30 minutes

In this session we will frame up the importance of time-to-market for new drugs, and explore the impact insight and understanding have in helping to reduce timelines across the BioPharma lifecycle.

Watch session

Closing Note

23rd June 2022 | 30 minutes

Christian Marcazzo, General Manager of IDBS, closes i3 2022 and is joined by Brian Hobbs, Engineering Director.

Watch session
See all i3 2022 Sessions
Christian Marcazzo

Christian Marcazzo has been the General Manager of IDBS since 2018, leading the business through a period of transition, investment and growth as a Danaher Operating Company. Prior to joining IDBS, Christian has spent 25 years at the interface of biology and software, leading organizations like Perkin Elmer, Spotfire and LION bioscience through the genomics revolution and the digitization of R&D. He has a BA in Molecular and Cell Biology from the University of California, Berkeley and is based at the IDBS headquarters in Surrey, UK.